A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
Author:
Open Access
- 1 December 2019
- journal article
- editorial
- Published by Georg Thieme Verlag KG in AIMS Genetics
- Vol. 06 (04) , 067-069
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Precision medicine becomes reality—tumor type‐agnostic therapyCancer Communications, 2018
- Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancerChinese Journal of Cancer, 2017
- Outcome of colon cancer initially presenting as colon perforation and obstructionWorld Journal of Surgical Oncology, 2017
- A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocationCell Death & Differentiation, 2017
- CircRNA: functions and properties of a novel potential biomarker for cancerMolecular Cancer, 2017
- Complete mesocolic excision and central vascular ligation for colon cancer: Principle, anatomy, surgical technique, and outcomesSurgical Oncology, 2016
- Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual PatientsJournal of Clinical Oncology, 2015
- A Circuitous Route to Noncoding RNAScience, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingAnnals of Oncology, 2012